LONG TERM SURVIVAL OF HIGH RISK MELANOMA PATIENTS IMMUNIZED WITH AN ALLOGENEIC WHOLE CELL GENETICALLY MODIFIED VACCINE (AGI-101) AFTER COMPLETE RESECTION
ANNALS OF ONCOLOGY（2010）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined